Jung Cassie - Insider Non-Derivative Transactions at Aquestive Therapeutics, Inc. (AQST) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 15, 2025, Jung Cassie's relationship to Aquestive Therapeutics, Inc. (AQST) is Officer (Chief Operating Officer), and currently has 308,346 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AQST insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
Jung Cassie - Insider Non-Derivative Transactions of AQST Common Stock
Jung Cassie - Insider Non-Derivative Transactions at AQST
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Oct 16, 2025 Sell -- (Common Stock) 67575 7.01 240771
Oct 16, 2025 M -- (Common Stock) 25000 3.1 308346
Sep 5, 2025 Sell -- (Common Stock) 62180 5 283346
Sep 5, 2025 M -- (Common Stock) 25000 3.15 320526
Sep 5, 2025 M -- (Common Stock) 25000 0.71 345526
Mar 11, 2025 F -- (Common Stock) 2182 2.54 295526
Mar 10, 2025 F -- (Common Stock) 7997 2.65 297708
Mar 8, 2025 F -- (Common Stock) 7361 2.65 305705
Mar 8, 2025 Acquisition -- (Common Stock) 80000 0 313066
Nov 27, 2024 Sell -- (Common Stock) 44 4.87 0
Mar 11, 2024 F -- (Common Stock) 1132 4.88 237754
Mar 10, 2024 F -- (Common Stock) 14120 4.88 233066
Mar 10, 2024 F -- (Common Stock) 8300 4.88 238886
Mar 8, 2024 Acquisition -- (Common Stock) 101250 0 247186
Mar 11, 2023 F -- (Common Stock) 1365 0 145936
Mar 10, 2023 Acquisition -- (Common Stock) 110000 0 146747